Ureteral mullerian carcinosarcoma (mixed mullerian tumor) associated with endometriosis occurring in a patient with a concentrated soy isoflavones supplementation

Archives of Gynecology and Obstetrics

Volumn 274, Issue 6, 2006, Pages 389-392

  Noel, Jean Christophe ^a   Anaf, Vincent ^a   Fayt, Isabelle ^a   Wespes, Eric ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Carcinosarcoma; Endometriosis; Isoflavone; Malignant transformation; Mixed mullerian tumor; Phytoestrogen; Soy; Ureter

Indexed keywords

DAIDZEIN; ESTROGEN; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

AGED; ARTICLE; CARCINOSARCOMA; CASE REPORT; DISEASE ASSOCIATION; ENDOMETRIOSIS; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MIXED MULLERIAN TUMOR; RARE DISEASE; SALPINGOOOPHORECTOMY; SOYBEAN;

AGED; CARCINOSARCOMA; CELL TRANSFORMATION, NEOPLASTIC; DIETARY SUPPLEMENTS; ENDOMETRIOSIS; FEMALE; HUMANS; ISOFLAVONES; MIXED TUMOR, MULLERIAN; SOYBEAN PROTEINS; URETERAL NEOPLASMS; UTERINE DISEASES;

EID: 33748955544     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0188-1     Document Type: Article

References (24)

1. Antonelli A, Simeone C, Frego E, Minimi G, Bianchi U, Cunico SC (2004) Surgical treatment of ureteral obstruction from endometriosis: our experience with thirteen cases. Int Urogynecol J Pelvic Floor Dysfunct 15:407-412
2. Booth C, Zahn CM, McBroom J, Maxwell GI (2004) Retroperitoneal mullerian carcinosarcoma associated with endometriosis: a case report. Gynecol Oncol 93:546-549
3. Brunson GL, Barclay DL, Sanders M, Araoz CA (1988) Malignant extraovarian endometriosis: two case reports and review of the literature. Gynecol Oncol 30:123-130
4. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57:359-383
5. Burton JL, Wells M (2002) The effect of phytoestrogens on the female genital tract. J Clin Pathol 55:401-407
6. Chang HY, Changchien CC, Chen HH, Lin H, Huang CC (2005) Extrauterine mullerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature. Int J Gynecol Cancer 15:361-365
7. Chumas JC, Thanning L, Mann WJ (1986) Malignant mixed mullerian tumor arising in extragenital endometriosis: report of a case and review of the literature. Gynecol Oncol 23:227-233
8. Comiter CV (2002) Endometriosis of the urinary tract. Urol Clin North Am 29:625-635
9. Cotroneo MS, Lamartiniere CA (2001) Pharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci 61:68-75
10. Donnez J, Nisolle M, Squifflet J (2002) Ureteral endometriosis: a complication of rectovaginal endometriotic (adenomyotic) nodules. Fertil Steril 77:32-37
11. Frohlich EP, Koller AB, van Blerk PJ, Margolius KA (1988) Adenocarcinoma from endometriosis causing urinary tract obstruction in a patient on oestrogen replacement therapy after hysterectomy. A case report. S Afr Med J 74:638-639
12. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN (1997) Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146:294-306
13. Hasiuk AS, Petersen RO, Hanjani P, Griffin TD (1984) Extragenital malignant mixed Mullerian tumor. Case report and review of the literature. Am J Clin Pathol 81:102-105
14. Jimenez RE, Tiguert R, Hurley P, An T, Grignon DJ, Lawrence D, Triest J (2000) Unilateral hydronephrosis resulting from intraluminal obstruction of the ureter by adenosquamous endometrioid carcinoma arising from disseminated endometriosis. Urology 56:331
15. Johnson EB, Muto MG, Yanushpolsky EH, Mutter GL (2001) Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol 98:947-950
16. Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryn J, Scudder S, Russell AH (2003) Endometriosis-related malignancies. Int J Gynecol Cancer 13:466-471
17. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and Sequols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12:1559-1567
18. Nezhat C, Nezhat F, Nezhat C, Nasserbakht F, Rosati M, Seidman DS (1996) Urinary tract endometriosis treated by laparoscopy. Fertil Steril 66:920-924
19. Salerno MG, Masciullo V, Naldini A, Zannoni GF, Vellone V, Scambia G (2005) Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis. Gynecol Oncol 99(3):749-752
20. Seidman JD (1996) Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 15:1-9
21. Shook TE, Nyberg LM (1988) Endometriosis of the urinary tract. Urology 31:1-6
22. Staar S, Richter DU, Makovitzky J, Briese V, Bergemann C (2005) Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ER alpha- and ER beta-mRNA and protein expression. Anticancer Res 25:1713-1718
23. Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ (2001) Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20:133-139
24. Zanetta GM, Webb MJ, Li H, Keeney GL (2000) Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 79:18-22